Utah Medical Products, Inc. (UTMD)
NASDAQHealth CareMedical - Instruments & SuppliesSnapshot 2026-09-04
$71.10+0.55%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - Instruments & SuppliesSnapshot 2026-09-04
QuarterlyIQ Insights · UTMD
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | 36.1 | 38.5 | 40.9 | 50.2 | 52.3 | 49.1 | 42.2 | 46.9 | 42.0 | 41.4 | 39.3 | 40.2 | 41.3 | 40.5 | 41.6 | 37.9 |
| Total Revenues | — | — | — | — | — | — | — | — | — | 41.4 | 39.3 | 40.2 | 41.3 | 40.5 | 41.6 | 37.9 |
| Cost of Revenues | 15.2 | 16.5 | 16.8 | 20.2 | 20.1 | 18.1 | 16.6 | 17.4 | 15.7 | — | — | — | — | — | — | — |
| Gross Profit | 20.9 | 22.0 | 24.1 | 30.0 | 32.2 | 30.9 | 25.5 | 29.5 | 26.3 | 26.4 | 23.7 | 24.2 | 25.0 | 24.3 | 25.3 | 22.4 |
| Operating Expenses & Income | ||||||||||||||||
| R&D Expenses | 0.7 | 0.7 | 0.8 | 0.6 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.4 | 0.5 | 0.5 | 0.5 | 0.5 | 0.6 | (0.5) |
| Other Operating Expenses, Total | — | — | — | — | — | — | — | — | — | (0.0) | 0.1 | (0.1) | (0.2) | (0.0) | (0.1) | 0.0 |
| Operating Income | 10.3 | 11.4 | 13.6 | 16.8 | 19.8 | 18.9 | 13.7 | 17.6 | 18.7 | 19.0 | 16.2 | 15.7 | 16.2 | 14.8 | 15.2 | 11.8 |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | — | — | — | — | — | — | — | — | — | 0.1 | 0.1 | 0.1 | 0.3 | 0.4 | 0.7 | 0.9 |
| EBT, Incl. Unusual Items | 12.9 | 14.1 | 16.8 | 20.1 | 20.7 | 19.1 | 13.8 | 17.9 | 19.5 | 19.1 | 16.4 | 15.5 | 15.8 | 14.5 | 14.5 | 11.1 |
| Income Tax Expense | 2.4 | 2.8 | 2.9 | 3.5 | 4.2 | 4.3 | 3.0 | 3.2 | 0.9 | 10.6 | 4.3 | 3.7 | 4.4 | 3.1 | 4.4 | 3.7 |
| Net Income | ||||||||||||||||
| Net Income | 10.5 | 11.3 | 13.9 | 16.6 | 16.5 | 14.8 | 10.8 | 14.7 | 18.6 | 8.5 | 12.1 | 11.8 | 11.4 | 11.4 | 10.2 | 7.4 |
| Per Share | ||||||||||||||||
| Basic EPS | 3.29 | 3.48 | 3.96 | 4.58 | 4.53 | 4.05 | 2.95 | 3.96 | 4.97 | 2.29 | 3.23 | 3.16 | 3.04 | 3.06 | 2.77 | 2.04 |
| Diluted EPS | 3.29 | 3.48 | 3.96 | 4.57 | 4.52 | 4.04 | 2.94 | 3.94 | 4.95 | 2.28 | 3.22 | 3.14 | 3.02 | 3.02 | 2.74 | 2.03 |
| Revenue per Share | 11.34 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 3.2 | 3.2 | 3.5 | 3.6 | 3.6 | 3.6 | 3.7 | 3.7 | 3.7 | 3.7 | 3.8 | 3.8 | 3.7 | 3.7 | 3.7 | — |
| Diluted Weighted Avg Shares | 3.2 | 3.2 | 3.5 | 3.6 | 3.6 | 3.7 | 3.7 | 3.7 | 3.7 | 3.7 | 3.8 | 3.8 | 3.8 | 3.8 | 3.7 | — |
| Supplemental | ||||||||||||||||
| EBIT | 10.3 | 11.4 | 13.6 | 16.8 | 19.8 | 18.9 | 13.7 | 17.6 | 18.7 | 19.0 | 16.2 | 15.7 | 16.2 | 14.8 | 15.2 | 11.8 |
| Effective Tax Rate | 18.6% | — | — | 17.2% | 20.3% | 22.4% | 22.0% | 17.7% | 4.6% | 55.4% | 26.1% | 23.8% | 28.0% | 21.2% | 30.0% | 33.1% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.